What should clinicians do for patients with hypertension and knee osteoarthritis?

      We have read with great interest the study (
      • Shi X.
      • Schlenk E.A.
      Association of hypertension with knee pain severity among people with knee osteoarthritis.
      ), which examined the association of hypertension with knee pain severity in individuals with knee osteoarthritis (OA). We would like to share our perspectives in this letter.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Pain Management Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arfè A.
        • Scotti L.
        • Varas-Lorenzo C.
        • Nicotra F.
        • Zambon A.
        • Kollhorst B.
        • Schink T.
        • Garbe E.
        • Herings R.
        • Straatman H.
        • Schade R.
        • Villa M.
        • Lucchi S.
        • Valkhoff V.
        • Romio S.
        • Thiessard F.
        • Schuemie M.
        • Pariente A.
        • Sturkenboom M.
        • Corrao G.
        • Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium
        Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: Nested case-control study.
        BMJ. 2016; 354: i4857
        • Chen B.
        • Duan J.
        • Wen S.
        • Pang J.
        • Zhang M.
        • Zhan H.
        • Zheng Y.
        An updated systematic review and meta-analysis of duloxetine for knee osteoarthritis pain (2021).
        Clinical Journal of Pain. 2021; 37: 852-862
        • Cheng B.R.
        • Chen J.Q.
        • Zhang X.W.
        • Gao Q.Y.
        • Li W.H.
        • Yan L.J.
        • Zhang Y.Q.
        • Wu C.J.
        • Xing J.L.
        • Liu JP
        Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: a systematic review and meta-analysis.
        PLoS One. 2021; 16e0261239
        • Daniilidis K.
        • Georges P.
        • Tibesku C.O.
        • Prehm P.
        Positive side effects of Ca antagonists for osteoarthritic joints-results of an in vivo pilot study.
        Journal of Orthopaedic Surgery and Research. 2015; 10: 1
        • Lafrance J.P.
        • Miller D.R.
        Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
        Pharmacoepidemiology and Drug Safety. 2009; 18: 923-931
        • Maddrey W.C.
        • Maurath C.J.
        • Verburg K.M.
        • Geis G.S.
        The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.
        American Journal of Therapeutics. 2000; 7: 153-158
        • Martín Arias L.H.
        • Martín González A.
        • Sanz Fadrique R.
        • Salgueiro Vázquez E.
        Gastrointestinal safety of coxibs: Systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2.
        Fundamental & Clinical Pharmacology. 2019; 33: 134-147
        • Pavlicević I.
        • Kuzmanić M.
        • Rumboldt M.
        • Rumboldt Z.
        Interaction between antihypertensives and NSAIDs in primary care: A controlled trial.
        Canadian Journal of Clinical Pharmacology. 2008; 15: e372-e382
        • Shi X.
        • Schlenk E.A.
        Association of hypertension with knee pain severity among people with knee osteoarthritis.
        Pain Management Nursing. 2022; 23: 135-141
        • Shin J.
        • Hills N.K.
        • Finley P.R.
        Combining antidepressants with β-blockers: Evidence of a clinically significant CYP2D6 drug interaction.
        Pharmacotherapy. 2020; 40: 507-516
        • Wallis J.A.
        • Webster K.E.
        • Levinger P.
        • Singh P.J.
        • Fong C.
        • Taylor N.F.
        A walking program for people with severe knee osteoarthritis did not reduce pain but may have benefits for cardiovascular health: A phase II randomised controlled trial.
        Osteoarthritis and Cartilage. 2017; 25: 1969-1979
        • Zhang Y.
        • Francis E..C.
        • Xia T.
        • Kemper K.
        • Williams J.
        • Chen L.
        Adherence to DASH dietary pattern is inversely associated with osteoarthritis in Americans.
        International Journal of Food Sciences and Nutrition. 2020; 71: 750-756